Synthetic data only. Never enter patient information; nothing is sent or stored. For clinicians. Not FDA cleared.For licensed clinicians. Educational demonstration on synthetic data. Never enter real patient identifiers or protected health information: everything runs in your browser and nothing is sent or stored. Clinical decision support only; not FDA cleared; physician review is required.
CPE-003 · synthetic case CKD-EX-12
Anemia, acidosis and mineral-bone signals in G4
Hemoglobin 10.2, bicarbonate 17 and persistently high phosphate.
Purpose: Hemoglobin 10.2, bicarbonate 17 and persistently high phosphate.
Inputs the engine received
Patient
- Age
- 67 years
Context
- Sex for equation
- male
- CKD confirmed
- Yes
- G category
- G4
- Initial anemia cause not explained
- Yes
- Phosphate persistently elevated
- Yes
Laboratory
- Hemoglobin
- 10.2 g/dL
- Bicarbonate
- 17 mmol/L
What the engine reports
Detected clinical pattern
CKD Criteria Met — Classification Incomplete
Chronicity is documented, but the A category (UACR) is missing, so risk classification is incomplete.
- Chronicity: Chronicity confirmed (≥3 months)
- Complication: anemia in ckd context
- Complication: low serum bicarbonate in ckd clinically significant
- Complication: possible ckd mbd biochemical pattern
Clinical summary
CKD criteria met on documented chronicity (); classification is incomplete without UACR. Physician adjudication required.
Patterns for physician adjudication
Evidence shown, not scored: pattern weights are not clinically validated.
Possible anemia of CKD context
Supporting
- Hemoglobin 10.2 g/dL
- Confirmed CKD G4
Contradicting or missing
- Iron studies and other causes not yet evaluated
Recommended next steps
For physician consideration. Urgent review always comes first.
- 1Specialist kidney-care referral per triggered criterion: Complex anemia / bone-disease complication.KDIGO 2024 referral criteria.
- 2Evaluate anemia with CBC, reticulocytes, ferritin and TSAT; a renal cause is not assigned before other causes are excluded.
- 3Clinician evaluation of persistence, cause and indication for treatment of low bicarbonate.
- 4Interpret serial phosphate, calcium and PTH together and evaluate modifiable factors and vitamin D status as clinically indicated.
Missing information
- UACR (required for the A category and risk assessment).
- UACR (required for the A category, risk assessment and a complete classification).
Why it matters
The result is placed in context so the physician can see what is established, what is provisional and what is missing.
Evidence and rule trace · 7 rules
CGA-001Assign G category from selected indexed eGFR
Inputs: G category G4 (documented)
G4 (15–29 mL/min/1.73 m²)
CGA-005Incomplete classification when UACR absent
Inputs: G4 · UACR missing
confirmed_ckd_incomplete_risk_classification
ANEMIA-001Anemia in CKD screening pattern
Inputs: hemoglobin 10.2 g/dL (<13 for male) · confirmed CKD
anemia_in_ckd_context: evaluate with CBC, reticulocytes, ferritin and TSAT; do not assign a renal cause without excluding others
ANEMIA-002Expanded anemia evaluation when initial workup insufficient
Inputs: initial anemia work-up unexplained
Consider smear, haptoglobin, LDH, CRP, B12, folate, liver tests, monoclonal protein evaluation, TSH, PTH and bleeding evaluation as clinically indicated
ACIDOSIS-001Low bicarbonate in CKD context
Inputs: bicarbonate 17 mmol/L
clinically significant acidosis risk
MBD-001Possible CKD-MBD biochemical pattern requires serial assessment
Inputs: persistent phosphate, PTH or calcium abnormality
possible_ckd_mbd_biochemical_pattern: interpret serial phosphate, calcium and PTH together
REF-001Nephrology referral triggers
Inputs: Complex anemia / bone-disease complication
Specialist kidney care referral indicated or to be considered per the triggered criterion
Evidence
- R1 · KDIGO 2024 Clinical Practice Guideline for the Evaluation and Management of Chronic Kidney Disease. Kidney Disease: Improving Global Outcomes (KDIGO), 2024.
- R5 · KDIGO 2026 Clinical Practice Guideline for the Management of Anemia in CKD - Executive Summary. KDIGO, 2026.
- R6 · KDIGO 2017 Clinical Practice Guideline Update for CKD-Mineral and Bone Disorder. KDIGO, 2017.
Physician adjudication required. Clinical decision support for physician review. Criteria-based status is not a probability. Findings require physician adjudication and correlation with the complete clinical context. Validation-only release: not for production clinical use.
Change the values
The same engine, starting from this case. Change any value and watch the pattern and the rule trace react.
Live eGFR and CGA map
eGFR (mL/min/1.73 m²)
—
enter a creatinine
| GFR \ ALB | A1<30 | A230–300 | A3>300 |
|---|---|---|---|
| G1≥90 | |||
| G260–89 | |||
| G3a45–59 | |||
| G3b30–44 | |||
| G415–29 | |||
| G5<15 |
No cell is shown until there are data. Colors follow the KDIGO risk heat map: green low, yellow moderately increased, orange high, red very high.
Kidney functionAdd a prior result with dates to test chronicity
Switches the engine to the combined eGFRcr-cys equation.
Albuminuria
Chemistry
Kidney findings and red flags
Context
Transient albuminuria confounders
Creatinine may be unreliable
Complications (persistent)
Therapy
Documented history and special populations
This case also carries values that have no field here: G_category, initial_anemia_cause_not_explained. They are included in the calculation until you clear the form.
More kidney cases
CKD-FX-001
Persistent moderately increased albuminuria with preserved GFR
Persistent moderately increased albuminuria with preserved GFR
CKD-FX-002
Persistent severely increased albuminuria with mildly decreased GFR
Persistent severely increased albuminuria with mildly decreased GFR
CKD-FX-003
Single reduced eGFR without chronicity
Single reduced eGFR without chronicity
CKD-FX-004
Acute creatinine rise before CKD staging
Acute creatinine rise before CKD staging
CKD-FX-005
Isolated suspected G3a requiring cystatin C confirmation support
Isolated suspected G3a requiring cystatin C confirmation support
CKD-FX-006
Combined eGFR reclassification support
Combined eGFR reclassification support
Try Biod in your practice
The Clinical Intelligence Layer — transforming fragmented clinical information into structured intelligence for clinician review and action.
